# Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)

> **NCT07692295** · — · NOT_YET_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- HIV

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT07692295
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-10
- **Final completion:** 2027-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692295, "Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*